S
Sven Mahner
Researcher at Ludwig Maximilian University of Munich
Publications - 545
Citations - 12728
Sven Mahner is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Ovarian cancer & Medicine. The author has an hindex of 46, co-authored 439 publications receiving 9126 citations. Previous affiliations of Sven Mahner include Charité & University of Hamburg.
Papers
More filters
Journal ArticleDOI
Publisher Correction: The psychological burden of COVID-19 on the desire for parenthood in minoritized sexual identities: a study on depressive symptoms and family planning in Germany
Journal ArticleDOI
The renaissance of hormonal therapy
TL;DR: In den 1980er-Jahren wurden Frauen in den Wechseljahren Hormone z. T. recht unkritisch verordnet. 2002 kam diese Therapie dann nach der Publikation der WHI-Studie in Verruf as mentioned in this paper.
Journal ArticleDOI
Nutzen einer digitalen Gesundheitsapplikation zum Symptommanagement während akuter COVID-19-Infektion bei ambulanten onkologischen PatientInnen
Rachel Würstlein,Timo Schinköthe,A König,Angelika Stefan,Fabian Trillsch,Alexander Burges,Sven Mahner,Nadia Harbeck,A. Chelariu-Raicu +8 more
TL;DR: Einleitung Aktive Kommunikation mit ambulanten onkologischen PatientInnen während akuter COVID-19-Infektion and häuslicher Quarantäne zu Therapie-and Symptommanagement ist entscheidend für den COVID19- and also für the weiteren onkologicischen Therapieverlauf as discussed by the authors .
Proceedings ArticleDOI
2022-RA-1725-ESGO Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer- results of a multicentre NOGGO phase I and II study (TOPAZ)
Tjadina Arndt,Radoslav Chekerov,Klaus Pietzner,Isil Yalcinkaya,Ulrich Canzler,Pauline Wimberger,A. Strauss,Sven Mahner,Linn Woelber,Nikolaus de Gregorio,Ulrich Hacker,E von Abel,Rolf Richter,Jalid Sehouli +13 more
TL;DR: In this article , an univariate analysis of the risk of recurrence after the first surgery was performed, and the results showed that the risk for recurrence was significantly higher after first surgery Factor Category Odds Ratio (IC 95%) P value Histology Serous 4 (0.6744003 23.72478) 0.10
Journal ArticleDOI
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
Lisa Hiepp,Doris Mayr,Kathrin Christina Gärtner,Elisa Schmoeckel,Frederick Klauschen,Alexander Burges,Sven Mahner,Reinhard Zeidler,Bastian Czogalla +8 more
TL;DR: It is indicated that CA XII plays a crucial role for the malignancy of ovarian carcinoma cells and emphasize the potential of CA XII as a diagnostic marker and therapeutic target in the management of Ovarian carcinomas.